Could oral phosphodiesterase 5 inhibitors have a potential adjuvant role in combating COVID-19 infection?

T Mostafa - Sexual medicine reviews, 2021 - academic.oup.com
Introduction The recent global outbreak of coronavirus disease 2019 (COVID-19) has
become a pandemic with a lot of sufferers. Excessive inflammation, exaggerated immune …
被引用次数：34 相关文章

Could Oral Phosphodiesterase 5 Inhibitors Have a Potential Adjuvant Role in Combating COVID-19 Infection?

T Mostafa - Sexual medicine reviews, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction The recent global outbreak of coronavirus disease 2019 (COVID-19) has
become a pandemic with a lot of sufferers. Excessive inflammation, exaggerated immune …

Could Oral Phosphodiesterase 5 Inhibitors Have a Potential Adjuvant Role in Combating COVID-19 Infection?

T Mostafa - Sexual Medicine Reviews, 2021 - Elsevier
Introduction The recent global outbreak of coronavirus disease 2019 (COVID-19) has
become a pandemic with a lot of sufferers. Excessive inflammation, exaggerated immune …

Could Oral Phosphodiesterase 5 Inhibitors Have a Potential Adjuvant Role in Combating COVID-19 Infection?

T Mostafa - Sexual Medicine Reviews, 2020 - europepmc.org
Introduction: The recent global outbreak of coronavirus disease 2019 (COVID-19) has
become a pandemic with a lot of sufferers. Excessive inflammation, exaggerated immune …
[HTML] nih.gov

[HTML][HTML] Could Oral Phosphodiesterase 5 Inhibitors Have a Potential Adjuvant Role in Combating COVID-19 Infection?

T Mostafa - Sexual Medicine Reviews, 2021 - ncbi.nlm.nih.gov
Objective To shed a light on the likely benefits of the oral phosphodiesterase 5 (PDE5)
inhibitor adjuvant role in combating COVID-19 infection. Methods A literature review was …